These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative. Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE; Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661 [TBL] [Abstract][Full Text] [Related]
4. Biomarkers in Alzheimer's disease. Lovestone S J Nutr Health Aging; 2006; 10(2):118-22. PubMed ID: 16554945 [No Abstract] [Full Text] [Related]
5. Problems associated with biological markers of Alzheimer's disease. Frey HJ; Mattila KM; Korolainen MA; Pirttilä T Neurochem Res; 2005 Dec; 30(12):1501-10. PubMed ID: 16362769 [TBL] [Abstract][Full Text] [Related]
6. [Clinical study of Alzheimer's disease. Early diagnosis and diagnostic criteria in Alzheimer's disease]. Nishimura T Nihon Rinsho; 1988 Jul; 46(7):1540-4. PubMed ID: 3221460 [No Abstract] [Full Text] [Related]
8. Of mind and matter--or what really matters in Alzheimer's disease? Neurobiological substrates of clinical deficits in Alzheimer's disease. Förstl H Eur Arch Psychiatry Clin Neurosci; 1996; 246(3):116-7. PubMed ID: 8739394 [No Abstract] [Full Text] [Related]
9. Peripheral biomarkers of oxidative damage in Alzheimer's disease: the road ahead. Praticò D Neurobiol Aging; 2005 May; 26(5):581-3. PubMed ID: 15708431 [No Abstract] [Full Text] [Related]
11. Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease. Khachaturian ZS Alzheimers Dement; 2011 May; 7(3):253-6. PubMed ID: 21575869 [No Abstract] [Full Text] [Related]
12. Biochemical markers of Alzheimer's disease: wish and reality. Papassotiropoulos A; Hock C Neurobiol Aging; 2002; 23(4):513-4. PubMed ID: 12009497 [No Abstract] [Full Text] [Related]
13. Alzheimer's disease and vascular dementia. Some points of confluence. Agüero-Torres H; Winblad B Ann N Y Acad Sci; 2000 Apr; 903():547-52. PubMed ID: 10818551 [TBL] [Abstract][Full Text] [Related]
14. Physiological fluctuations in white matter are increased in Alzheimer's disease and correlate with neuroimaging and cognitive biomarkers. Makedonov I; Chen JJ; Masellis M; MacIntosh BJ; Neurobiol Aging; 2016 Jan; 37():12-18. PubMed ID: 26476600 [TBL] [Abstract][Full Text] [Related]
15. Medical Clinics of North America. Early diagnosis and intervention in predementia Alzheimer's disease. Preface. Molinuevo JL; Cummings JL; Dubois B; Scheltens P Med Clin North Am; 2013 May; 97(3):xiii-xv. PubMed ID: 23642584 [No Abstract] [Full Text] [Related]
16. On understanding Alzheimer's disease. Raskin DE Am J Psychiatry; 1985 Oct; 142(10):1225. PubMed ID: 4037140 [No Abstract] [Full Text] [Related]
17. Progress in clinical neurosciences: cognitive markers of progression in Alzheimer's disease. Behl P; Stefurak TL; Black SE Can J Neurol Sci; 2005 May; 32(2):140-51. PubMed ID: 16018149 [TBL] [Abstract][Full Text] [Related]
18. An improved model for disease progression in patients from the Alzheimer's disease neuroimaging initiative. Samtani MN; Farnum M; Lobanov V; Yang E; Raghavan N; Dibernardo A; Narayan V; J Clin Pharmacol; 2012 May; 52(5):629-44. PubMed ID: 21659625 [TBL] [Abstract][Full Text] [Related]
19. [Early diagnosis in Alzheimer's disease protects competence]. Glatz U Dtsch Med Wochenschr; 2012 Mar; 137(11):p9. PubMed ID: 22421909 [No Abstract] [Full Text] [Related]